IL1B and inflammatory bowel disease: In IBD, pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 activate immune cells, promote inflammatory responses, and disrupt the intestinal epithelial barrier, leading to the loss of intestinal function and pathological changes [120].